Company Description
CompuMed (OTC Link: CMPD) is a publicly traded health information services company in the Healthcare sector. The company has a market capitalization of $5.9M.
CMPD stock has gained 82.8% over the past year. Shares last traded at $6.00.
This page provides a comprehensive overview of CMPD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CompuMed (CMPD) stock last traded at $6.00, up 7.50% from the previous close. Over the past 12 months, the stock has gained 82.8%. At a market capitalization of $5.9M, CMPD is classified as a micro-cap stock with approximately 1.3M shares outstanding.
Latest News
CompuMed has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 4 with negative movement. Key topics include management, earnings, stock split. View all CMPD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in CompuMed (CMPD) currently stands at 5.9 thousand shares, up 12.2% from the previous reporting period. Over the past 12 months, short interest has increased by 15.8%.
Days to Cover History
Days to cover for CompuMed (CMPD) currently stands at 2.7 days. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 77.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 13.6 days.
CMPD Company Profile & Sector Positioning
CompuMed (CMPD) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CMPD often look at related companies in the same sector, including Careview Comm (CRVW), Comprehensive Healthcare Systems (CMHSF), AI / ML Innovations (AIMLF), DiagnaMed Holdings Corp (DGNMF), and Imaging (IQAIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CMPD's relative position within its industry.